adopted since 2020, which impact to rental decrease THB 1,959 million, depreciation increase THB 1,746 million, financial cost increase THB 355 million, and administrative expenses decrease THB 8 million
its newly issued shares within Q2 2020/21. The remaining of 10.0% investment through the purchase of existing shares is expected to complete within Q3 2020/21. About VGI Vietnam VGI Vietnam is a leading
% 469.70 58.4% 466.66 59.8% -0.7% -3.0% Advertising income 4.04 0.5% 2.71 0.3% 3.41 0.4% 25.8% -15.6% Total revenue from core business (3 items) 831.82 100.0% 804.20 100.0% 780.16 100.0% -3.0% -6.2% Cost of
% from Q3/2020 and 24% from 9M/2020 due to a decrease in revenue while the Company still recognized a stable fixed cost. • EBITDA margin in Q3/2021 was 20.7%, decreased from 32.7% in Q3/2020 and in 9M/2021
fluctuation can incur costs to users and recipients e.g. digital asset conversion fees.1.2) IT risk: Consumers may face cyber theft, personal data leaks, or opportunity cost in instances of system failure
higher selling price and higher sale volume in CNF incoterm, while lower unit sold and appreciation of Thai baht against US dollar. . Cost of goods sold and expenses Three-month (Thousands Baht) Change
their services to all customers. The Company, leading distributor of medical device, is developing new products; medical software, together with plan to shift from distributor to manufacture to serve
government has policies to help the cost of living of people at the grassroots level, it focuses on spending of the essential consumer products only. Products of the Company: For Medical Devices; There is
revenue 792 852 978 14.9% 23.5% Cost of sales 326 356 387 8.8% 19.0% Gross profit 466 496 591 19.2% 26.7% EBITDA 320 352 444 26.0% 38.8% Adjusted EBITDA1 324 361 451 25.1% 39.2% EBIT 236 251 333 32.5% 41.3